For example, if a missense variant in RYR1 alters protein function and causes malignant hyperthermia when expressed in skeletal muscle, then we hypothesise that a novel variant affecting the equivalent amino acid in RYR2, expressed in cardiac muscle, is likely to be disease causing in a patient with CPVT. The gene discussed is RYR2; the disease is Malignant hyperthermia.